Celldex Therapeutics
CLDX
#4691
Rank
S$2.54 B
Marketcap
S$38.35
Share price
6.44%
Change (1 day)
7.39%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$64.88 Million

According to Celldex Therapeutics's latest financial reports the company's total liabilities are S$64.88 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$61.62 M27.99%
2023-12-31S$48.14 M35.37%
2022-12-31S$35.56 M4.49%
2021-12-31S$34.03 M-2.84%
2020-12-31S$35.03 M-10.11%
2019-12-31S$38.97 M-10.15%
2018-12-31S$43.37 M-59.08%
2017-12-31S$0.10 B-37.89%
2016-12-31S$0.17 B154.13%
2015-12-31S$67.16 M39.81%
2014-12-31S$48.03 M38.88%
2013-12-31S$34.58 M-4.98%
2012-12-31S$36.4 M-3.97%
2011-12-31S$37.9 M-15.16%
2010-12-31S$44.68 M-52.21%
2009-12-31S$93.49 M26.55%
2008-12-31S$73.87 M388.65%
2007-12-31S$15.11 M-83.38%
2006-12-31S$90.95 M251.03%
2005-12-31S$25.91 M114.76%
2004-12-31S$12.06 M109.77%
2003-12-31S$5.75 M-14.76%
2002-12-31S$6.74 M-55.63%
2001-12-31S$15.2 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Seagen
SGEN
S$1.40 B 2,064.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.66 B 927.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.13 B 1,654.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.33 B 160,699.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.83 B 230,819.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.40 B 122,282.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
S$0.34 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA